It is a chemicals private limited company based in Bangalore, Karnataka, India, established in 2007.
2007 | Bangalore, Karnataka, India | Struck OffScandent Pharmaceuticals Private Limited, a struck off private limited company, was established on 15 June 2007 in Bangalore, Karnataka, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230KA2007PTC043142. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Its leadership includes Tarikere Kumaraswamy Sudhir (Additional Director), Kalasapura Srinivasmurthy Ramprasad (Additional Director). Past directors included Ramakrishna Bramaramba Ganeshamurthy, Sushilendrachan Nanjungud Suyameendra. Its latest AGM occurred on 30 September 2010, with the balance sheet filed on 31 March 2010. It is based at No #7/A, Ground Floor, 4Th Cross, Nehru Road 1St Phase, Girinagar, Bangalore, Karnataka, 560085.
U24230KA2007PTC043142
043142
15 June 2007
₹1.00 M
₹0.50 M
Roc Bangalore
Unlisted
Struck Off
Explore comprehensive insights into Scandent Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tarikere Kumaraswamy Sudhir | Additional Director | 02 Dec 2009 | Current |
| Kalasapura Srinivasmurthy Ramprasad | Additional Director | 02 Dec 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 04 Dec 2009 | Past |
| Pramod Abcsdd | Director | 04 Dec 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Scandent Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Scandent Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Scandent Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Scandent Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scandent Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Scandent Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records. was completed.
Progress on Scandent Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Bangalore. was documented.
Tarikere Kumaraswamy Sudhir was appointed as a Additional Director was appointed as a Additional Director on 02 Dec 2009 & has been associated with this company since 16 years 1 month . was recorded as a recent event.
The activity Kalasapura Srinivasmurthy Ramprasad was appointed as a Additional Director was appointed as a Additional Director on 02 Dec 2009 & has been associated with this company since 16 years 1 month . was completed.
The activity Scandent Pharmaceuticals Private Limited was registered on 15 Jun 2007 with Roc Bangalore & aged 18 years 7 months as per MCA records. was completed.
The CIN of Scandent Pharmaceuticals Private Limited is U24230KA2007PTC043142.
Scandent Pharmaceuticals Private Limited is headquartered at No #7/A, Ground Floor, 4Th Cross, Nehru Road 1St Phase, Girinagar, Bangalore, Karnataka, 560085.
Scandent Pharmaceuticals Private Limited was incorporated on 15 June 2007.
The current directors of Scandent Pharmaceuticals Private Limited are
The primary industry of Scandent Pharmaceuticals Private Limited is Chemicals.
Scandent Pharmaceuticals Private Limited is unlisted.
The authorized capital of Scandent Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX